STOK - Stoke Therapeutics Inc
IEX Last Trade
14.57
0.670 4.598%
Share volume: 612,652
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$13.90
0.67
4.82%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-14 | 2023-03-06 | 2023-05-04 | 2023-08-07 | 2023-11-07 | 2024-03-25 | 2024-05-06 | |
| Assets | |||||||||
| Total Assets | 301.427 M | 277.626 M | 256.067 M | 281.796 M | 256.919 M | 239.889 M | 228.342 M | 205.182 M | |
| Current Assets | 289.159 M | 264.601 M | 244.070 M | 270.236 M | 246.232 M | 230.019 M | 215.339 M | 193.275 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 13.179 M | 12.551 M | 13.887 M | 16.071 M | 14.649 M | 15.205 M | 13.881 M | 14.683 M | |
| Short Term Investments | 13.179 M | 12.551 M | 13.887 M | 16.071 M | 14.649 M | 15.205 M | 13.881 M | 14.683 M | |
| Total Receivables | 350.000 K | 395.000 K | 588.000 K | 492.000 K | 136.000 K | 96.000 K | 64.000 K | 11.000 K | |
| Current Cash | 275.630 M | 251.655 M | 229.595 M | 253.673 M | 231.447 M | 214.718 M | 201.394 M | 178.581 M | |
| Total Non-current Assets | 12.268 M | 13.025 M | 11.997 M | 11.560 M | 10.687 M | 9.870 M | 13.003 M | 11.907 M | |
| Property Plant Equipment | 5.868 M | 7.161 M | 6.675 M | 6.789 M | 6.472 M | 6.217 M | 5.823 M | 5.278 M | |
| Other Assets | 5.831 M | 5.295 M | 4.753 M | 4.202 M | 3.646 M | 3.084 M | 6.611 M | 6.060 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 301.427 M | 277.626 M | 256.067 M | 281.796 M | 256.919 M | 239.889 M | 228.342 M | 205.182 M | |
| Total liabilities | 77.106 M | 73.483 M | 71.218 M | 67.974 M | 66.724 M | 66.890 M | 68.777 M | 64.840 M | |
| Total current liabilities | 27.649 M | 28.795 M | 31.394 M | 31.527 M | 21.837 M | 25.201 M | 30.819 M | 35.590 M | |
| Accounts Payable | 3.602 M | 1.911 M | 766.000 K | 4.299 M | 1.556 M | 3.076 M | 1.695 M | 2.102 M | |
| Other liabilities | 49.457 M | 44.688 M | 39.824 M | 36.447 M | 44.887 M | 41.689 M | 37.958 M | 29.250 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 49.457 M | 44.688 M | 39.824 M | 36.447 M | 44.887 M | 41.689 M | 37.958 M | 29.250 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 224.321 M | 204.143 M | 184.849 M | 213.822 M | 190.195 M | 172.999 M | 159.565 M | 140.342 M | |
| Common stock | 39.258 M | 39.420 M | 39.463 M | 42.536 M | 44.188 M | 44.266 M | 44.988 M | 46.247 M | |
| Retained earnings | -245.384 M | -271.495 M | -297.150 M | -319.695 M | -350.349 M | -374.891 M | -401.849 M | -428.223 M |